Intensified MR-guided pulsed adaptive cancer treatment- a potential new treatment option for large(>5cm) central non-small cell lung cancer, a case report - Scorecard - MDSpire
Advertisement
Intensified MR-guided pulsed adaptive cancer treatment- a potential new treatment option for large(>5cm) central non-small cell lung cancer, a case report
Clinical Scorecard: Enhanced MR-guided Pulsed Adaptive Therapy: A Novel Approach for Treating Large (>5cm) Central Non-Small Cell Lung Cancer - A Case Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Adaptive radiotherapy (ART) guided by MR-Linac systems for real-time treatment adjustments.
Target Population
Care Setting
Key Highlights
Significant tumor regression observed (from 79 mm to 17 mm) after MR-guided adaptive radiotherapy.
No acute or late toxicity reported during treatment.
Guideline-Based Recommendations
Diagnosis
Use imaging techniques such as MRI and PET-CT for diagnosis and treatment planning.
Management
Consider MR-guided adaptive radiotherapy for large, inoperable thoracic lesions.
Monitoring & Follow-up
Continuously monitor intrafractional tumor motion using real-time MR imaging.
Risks
Be aware of potential pulmonary toxicity associated with immunotherapy.
Patient & Prescribing Data
Stage IV NSCLC patients with large tumors and poor response to prior treatments
Nivolumab monotherapy continued after initial combination therapy due to toxicity
Clinical Best Practices
Utilize adaptive radiotherapy techniques to improve target coverage and reduce toxicity.
